Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
08/1999
08/24/1999US5942210 Methods for lyoprotecting a macromolecule using tricine
08/24/1999US5942209 Polymerizing a biodegradable, biocompatible polymer vehicle, e.g. epoxide-containing polymer, polyester, polyurethane, polyamide, polysulfone or an addition polymer, containing radionuclides; drug delivery
08/19/1999WO1999040947A2 Angiogenesis targeting molecules
08/19/1999WO1999040882A2 STEREOSELECTIVE Tc-99m LIGANDS
08/19/1999WO1999022670A3 In-situ radioactive stent
08/19/1999CA2320339A1 Angiogenesis targeting molecules
08/18/1999EP0935654A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use
08/18/1999EP0651799B1 Fibrin binding domain polypeptides and uses and methods of producing same
08/17/1999CA2034042C Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
08/12/1999WO1999039765A2 Soft x-ray emitting medical devices
08/12/1999WO1999039748A1 Targeting immunoreagents useful in therapeutic and diagnostic compositions and methods
08/12/1999WO1999039747A1 Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi
08/12/1999WO1999039746A2 Radioactive seed implants
08/12/1999CA2319248A1 Radioactive seed implants
08/12/1999CA2319029A1 Soft x-ray emitting medical devices
08/11/1999EP0934405A1 Melanoma associated peptide analogues and vaccines against melanoma
08/11/1999EP0912218A4 TECHNETIUM-99m GENERATOR SYSTEM
08/11/1999CN1225279A Radioactive rhenium marking tin-sulphur colloid agent, prepn. method and use therefor
08/05/1999WO1999038889A2 Modulation of sodium channels in dorsal root ganglia
08/05/1999WO1999038884A2 Method and means for site directed therapy
08/05/1999WO1999038866A1 8-azabicyclo[3.2.1]oct-2-ene derivatives in labelled form and use of 8-azabicyclo[3.2.1]oct-2-ene derivatives in labelled and unlabelled form
08/05/1999WO1999038500A2 The human calcium-sensing receptor in the detection and treatment of cancer
08/05/1999WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules
08/05/1999CA2319143A1 Modulation of sodium channels in dorsal root ganglia
08/04/1999EP0932420A1 Drug delivery using terminal complement components
08/04/1999EP0932417A1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
08/04/1999EP0932399A1 Water soluble paclitaxel prodrugs
08/04/1999EP0810989B1 Novelly substituted dtpa derivatives, metal complexes thereof, pharmaceuticals containing these complexes, diagnostic and therapeutic uses thereof and methods for preparing the complexes and pharmaceuticals
08/04/1999EP0784634A4 Modified radioantibody fragments for reduced renal uptake
08/04/1999EP0702570B1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION
08/04/1999EP0644775B1 Cocaine Receptor Binding Ligands
08/03/1999US5932707 Thioether-containing metal chelating compounds
08/03/1999US5932217 Peptides which inhibit adhesion between leukocytes and endothelial cells
08/03/1999US5932189 Radiotherapy, radiodiagnosis peptides
08/03/1999US5932188 Therapeutic and diagnostic imaging compositions and methods
07/1999
07/29/1999WO1999037683A1 MONOCLONAL ANTIBODY ANTI αv-INTEGRIN AND ITS USE TO INHIBIT αvβ6-INTEGRIN ATTACHMENT TO FIBRONECTIN
07/29/1999WO1999024081A3 A radionuclide-binding compound and its delivery system
07/29/1999CA2319160A1 Monoclonal antibody anti .alpha.v-integrin and its use to inhibit .alpha.v.beta.6-integrin attachment to fibronectin
07/28/1999EP0931147A1 ANTI-ErbB2 ANTIBODIES
07/28/1999EP0930844A1 Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent
07/28/1999EP0805703B1 Balloon catheter used to prevent re-stenosis after angioplasty and process for producing a balloon catheter
07/27/1999US5928873 Testing extraintestinal tissues or body fluids for presence of heat stable toxin receptor protein, comparing to negative control assay, increased presence indicates metastasis
07/22/1999WO1999036552A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy
07/22/1999WO1999036105A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
07/22/1999WO1998046276A8 Chelating agents
07/22/1999CA2318231A1 Use of radiolabeled monoclonal igm in therapy for cancer and autoimmune disease
07/21/1999EP0929574A1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS
07/21/1999EP0929319A1 Dopamine and serotonin transporter ligands and imaging agents
07/21/1999EP0929303A2 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agent
07/21/1999EP0929300A2 Cyanidin compositions and therapeutic and diagnostic uses therefor
07/21/1999CN1223685A Modulators of tissue regeneration
07/21/1999CN1223146A Tris(isontrile) cooper (1) sulfates for preparing radionuclide complexes
07/20/1999US5925353 Targeted radioimmunotherapy
07/20/1999US5925332 Radioimaging and radiochemotherapy phenolic thioether amines and acyl derivatives thereof for use in diagnosing and treating pigmentation disorders
07/20/1999US5925331 Technetium-99m labeled peptides for thrombus imaging
07/20/1999US5924973 Method of treating a disease process in a luminal structure
07/20/1999CA1340665C Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
07/15/1999WO1999035134A1 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
07/15/1999WO1999034838A2 Nuclear scintigraphic assessment of mucosal function
07/15/1999WO1999034827A1 Activated t-cells and their uses
07/15/1999WO1999034779A1 Magnetically responsive composition
07/15/1999DE19801154A1 Preparation of pure recombinant thyroid stimulating hormone receptor useful for detection of autoantibodies in human serum
07/15/1999CA2318471A1 Nuclear scintigraphic assessment of mucosal function
07/14/1999EP0928204A1 Measurement of liquid phase gastric emptying
07/13/1999US5922303 Technetium-99M labeled peptides for imaging
07/13/1999US5922302 Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
07/13/1999US5922301 Radiolabelled amino acid formulations stored in an unfrozen state
07/08/1999WO1999033863A1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center
07/08/1999WO1999033766A1 Method for making apatite ceramics, in particular for biological use
07/08/1999WO1999011604A9 Sterilized 5-aminolevulinic acid
07/08/1999DE19807727A1 Radioactive balloon for a balloon-dilatation-catheter system for effective prevention of restenosis
07/08/1999CA2316392A1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center
07/07/1999EP0927558A1 Embolizing compositions comprising surfactants
07/07/1999EP0927049A2 Labelled elastase inhibitors
07/07/1999EP0927045A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same
07/07/1999EP0728019A4 Labelled diagnostic compositions and methods of their use
07/07/1999EP0637336B1 Mn gene and protein
07/07/1999EP0502188B1 Cloned glutamic acid decarboxylase
07/06/1999US5919934 Bisaminothiol and amino compounds with appended pharmacophores, metal complexes of these compounds;
07/06/1999US5919797 Halogenated naphthyl methoxy piperidines for mapping serotonin transporter sites
07/06/1999US5919456 IL-13 receptor specific chimeric proteins
07/06/1999US5919442 Hyper comb-branched polymer conjugates
07/06/1999US5919431 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceutical agents containing these compounds and process for their production
07/06/1999US5919126 Coronary stent with a radioactive, radiopaque coating
07/01/1999WO1999032167A1 Glass fiber chemical delivery system
07/01/1999DE19741695C1 Treatment of proliferative disorders, i.e. atherosclerosis and tumors
06/1999
06/30/1999EP0925506A1 Agonist-dependent internalization of human somatostatin receptors types 1-5
06/30/1999EP0925359A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
06/30/1999EP0563328B1 Tc(III)-99m MYOCARDIAL IMAGING AGENTS AND METHOD OF USE
06/29/1999US5916792 Jak3 plays a role in the growth factor modulated differentiation/proliferation of the stem/progenitor cells.
06/29/1999US5916561 Monoclonal antibody against CD44v6
06/29/1999US5916538 Administering to a subject an effective dose of glucose labelled with carbon, measuring lelvels of exhaled carbon dioxide for a specific time and compare the level to normal is indicative of diabetic condition
06/29/1999US5916537 Diagnostic and diagnosis method for central nervous abnormality and phenylketonuria
06/24/1999WO1999030745A2 Dota-biotin derivatives
06/23/1999EP0923538A1 Compounds which can form complexes with metals
06/22/1999US5914352 Methods for the use of stabilized fluorocarbon emulsions
06/22/1999US5914312 Pretargeting methods and compounds
06/22/1999US5914097 Reacting an anhdride with amino acid or ester or amide to form a polydentate amino-acyl type chelator
06/22/1999US5914096 Arsenic-72 labeled compounds for tissue specific medical imaging
06/19/1999CA2225326A1 A simple and efficient method to prepare technetium-99m labelled peptides